Seminar on T1D technology followed by Sabrina Lyngbye Wendt's PhD defense

On July 6, 2017, PhD student Sabrina Lyngbye Wendt will defend her PhD thesis at Technical University of Denmark in continuation of a seminar on type 1 diabetes technology featuring Roman Hovorka, University of Cambridge and Chiara Dalla-Man, University of Padova. Everybody is welcome to attend.

TIME & LOCATION OF SEMINAR AND PHD DEFENSE

6 July 2017, 10:00 AM-13:50 PM

Technical University of Denmark (DTU)
Richard Petersens Plads
DK-2800 Kgs. Lyngby

Seminar, DTU Building 303B, Room 026

10:00-10:45  Roman Hovorka, University of Cambridge: Hybrid closed-loop glucose control
10:45-11:30  Chiara Dalla-Man, University of Padova: The UVa/Padova type 1 diabetes simulator and its use in in silico clinical trials

PhD defense, DTU Building 101, Meeting Room 1

13:05-13:50  PhD Presentation. Sabrina Lyngbye Wendt, Zealand Pharma A/S: Modeling Pharmacokinetics and Pharmacodynamics of Glucagon for Simulation of the Glucoregulatory System in Patients with Type 1 Diabetes

COMMITTEE OF EXAMINERS FOR THE PHD DEFENSE

Associate Professor Uffe Høgsbro Thygesen, DTU Compute 
Director of Research Roman Hovorka, University of Cambridge, UK
Associate Professor Chiara Dalla-Man, University of Padova, Italy

Chairperson: Associate Professor Yiqiu Dong, DTU Compute

PRINCIPAL SUPERVISOR OF SABRINA LYNGBYE WENDTS

Associate Professor John Bagterp Jørgensen, DTU Compute

Professor Henrik Madsen, DTU Compute (co-supervisor)
Dr. Carsten Boye Knudsen, Zealand Pharma A/S (co-supervisor)

For further information about the PhD defense and seminar, please contact John Bagterp Jørgensen, jbjo@dtu.dk